导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.56% | 653/1050 |
| 近一周 | -3.02% | 923/1104 |
| 近一月 | -2.56% | 454/1103 |
| 近一季 | 0.78% | 267/1092 |
| 近半年 | -8.65% | 736/1070 |
| 近一年 | 6.80% | 437/1018 |
| 近两年 | 61.41% | 427/926 |
| 近三年 | 40.69% | 330/834 |
| 成立以来 | 138.01% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.89% 346/1070 |
-9.99% 907/1101 |
- - |
- - |
| 2025 | 35.44% 389/1065 |
5.34% 391/1014 |
-2.15% 854/1038 |
22.02% 540/1050 |
7.69% 77/1065 |
| 2024 | 10.16% 285/1011 |
1.14% 254/960 |
-0.36% 330/983 |
14.20% 284/991 |
-4.29% 613/1011 |
| 2023 | -2.94% 157/952 |
5.48% 295/880 |
-2.76% 357/895 |
-3.12% 208/915 |
-2.32% 256/952 |
| 2022 | -28.29% 584/867 |
-15.87% 303/773 |
5.76% 475/806 |
-13.14% 471/845 |
-7.21% 710/867 |
| 2021 | -1.54% 373/740 |
- - |
- - |
- - |
3.18% 296/740 |
| 2020 | 42.48% 285/554 |
- - |
- - |
- - |
- - |
| 2019 | 42.81% 199/410 |
- - |
- - |
- - |
- - |
| 2018 | -20.69% 92/349 |
- - |
- - |
- - |
- - |
| 2017 | 27.91% 50/285 |
- - |
- - |
- - |
- - |
| 2016 | 6.36% 14/205 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇丰晋信大盘股票H VS. 东吴新产业精选股票A(580008) |